Veena Shankaran, MD, MS; Hannah Linden, MD; Jordan Steelquist, BA; Kate Watabayashi, BA; Karma Kreizenbeck, BA; Tony Leahy, JD; and Karen Overstreet, JD
This paper describes results from a patient survey regarding treatment-related financial experiences and interest in a financial literacy course.
Andrea Baer, MS, and Marcia Baker, MS Ed
How peer-to-peer, community support programs can educate and empower patients to become more adherent to treatments, which will improve outcomes and reduce healthcare costs.
Dan Klein, President and CEO, Patient Access Network Foundation
This supplement showcases the winning papers and case studies from the PAN Challenge, which aimed to stimulate a dialogue on ways to reduce or eliminate the barriers and disparities that Medicare and ACA enrollees face in obtaining medications to treat life-threatening, chronic, and rare diseases.
Jalpa A. Doshi, PhD; Pengxiang Li, PhD; Amy R. Pettit, PhD; J. Samantha Dougherty, PhD; Ashley Flint, MPP; and Vrushabh P. Ladage, BS
Medicare claims analyses offer insight into how proposed policy changes would affect out-of-pocket prescription costs for Part D beneficiaries requiring specialty drugs.
Kai Yeung, PharmD, PhD; Anirban Basu, PhD; Zachary A. Marcum, PharmD, PhD; John B. Watkins, PharmD, MPH, BCPS; and Sean D. Sullivan, PhD
A value-based formulary was implemented that used cost-effectiveness analysis to inform medication co-payments. Diabetes cohort expenditures decreased by $9 per member per month.